Načítá se...

Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling

Platinum-based regimens have been routinely used in the clinical treatment of patients with esophageal squamous cell carcinoma (ESCC). However, administration of these drugs is frequently accompanied by drug resistance. Revealing the underlying mechanisms of the drug resistance and developing agents...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Cell Dev Biol
Hlavní autoři: Cui, Wei, Fang, Tingting, Duan, Zhaoheng, Xiang, Dongfang, Wang, Yanxia, Zhang, Mengsi, Zhai, Fangzheng, Cui, Xiang, Yang, Lang
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7758349/
https://ncbi.nlm.nih.gov/pubmed/33363149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.596788
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!